The recommended dosage is a single transdermal system applied to the upper outer arm a minimum of 24 hours, up to a maximum of 48 hours, before chemotherapy. The transdermal system should be worn at minimum, 24 hours after chemotherapy is finished. The transdermal system can be worn for up to 7 days.
Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance
How to sign up
Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
patient education
Sancuso Patient Education
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link
people also ask
Sancuso FAQs
How is the dosage of Sancuso?Sancuso is available in 1 dosages, including 0.129 mg/hr 168 HR Patch
What does Sancuso treat?Sancuso treats
What is Sancuso made of?Sancuso contains granisetron which is a Serotonin-3 Receptor Antagonist
How Is Sancuso Administered?Sancuso is administered as a Transdermal
What Are The Sancuso Mechanism Of Action?Sancuso mechanism of action is Serotonin 3 Receptor Antagonists
FAQ Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available
